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Abstract
Background: There is a lack of consensus regarding the use of quality scores in diagnostic
systematic reviews. The objective of this study was to use different methods of weighting items
included in a quality assessment tool for diagnostic accuracy studies (QUADAS) to produce an
overall quality score, and to examine the effects of incorporating these into a systematic review.
Methods: We developed five schemes for weighting QUADAS to produce quality scores. We
used three methods to investigate the effects of quality scores on test performance. We used a set
of 28 studies that assessed the accuracy of ultrasound for the diagnosis of vesico-ureteral reflux in
children.
Results: The different methods of weighting individual items from the same quality assessment tool
produced different quality scores. The different scoring schemes ranked different studies in
different orders; this was especially evident for the intermediate quality studies. Comparing the
results of studies stratified as "high" and "low" quality based on quality scores resulted in different
conclusions regarding the effects of quality on estimates of diagnostic accuracy depending on the
method used to produce the quality score. A similar effect was observed when quality scores were
included in meta-regression analysis as continuous variables, although the differences were less
apparent.
Conclusion:  Quality scores should not be incorporated into diagnostic systematic reviews.
Incorporation of the results of the quality assessment into the systematic review should involve
investigation of the association of individual quality items with estimates of diagnostic accuracy,
rather than using a combined quality score.
Background
Quality assessment is as important in systematic reviews
of diagnostic accuracy studies as it is for any other system-
atic review. One method of incorporating quality into a
review is to use a quality score. Quality scores combine the
individual items from a quality assessment tool to provide
an overall single score. One of the main problems with
quality scores is determining how to weight each item to
provide an overall quality score. There is no objective way
of doing this and different methods are likely to produce
different scores that may lead to different results if these
scores are used in the analysis.
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There has been much discussion regarding the use of qual-
ity scores in the area of clinical trials[1-4,4-8]. Although
this discussion has not been specific to diagnostic accu-
racy studies much of these discussions also apply to this
topic area. Previous work illustrating the problems associ-
ated with quality scores has used different scales, which
not only weighted items differently but also included dif-
ferent items[9]. It has been argued that it was the differ-
ences in the items covered by the tools that contributed to
the differences found, rather than the use of a combined
quality score[2,3,6]. The debate regarding quality scores
remains and quality scores continue to be used as part of
the quality assessment process in both therapeutic and
diagnostic systematic reviews [10-14]. The Jadad scale,
one of the most commonly used quality assessment tools
for therapeutic studies, incorporates a quality score[15], as
does one of the commonly used diagnostic quality assess-
ment tools[16]. A recent review of existing quality assess-
ment tools for diagnostic accuracy studies found that 12
of 67 tools (18%) incorporated a quality score[17]. A fur-
ther review of how quality assessment has been incorpo-
rated into systematic reviews found that 16% of reviews
that performed some form of quality assessment used
quality scores as part of this assessment[18].
We are not aware of any work that has looked at the effect
of using different weightings for the same quality assess-
ment tool to produce an overall quality score or that has
been done in the area of diagnostic accuracy studies. This
project presents a practical example of the problems asso-
ciated with the use of quality scores in systematic reviews.
The aim is to use QUADAS, a quality assessment tool that
we recently developed to assess the quality of diagnostic
accuracy studies included in systematic reviews[19], to
investigate the effect of different weightings on estimates
of test performance.
Methods
Scoring methods
QUADAS does not incorporate a quality score. We there-
fore developed five different schemes for weighting QUA-
DAS (Table 1) to produce an overall study quality score:
1. Equal weighting
All items were weighted equally and scored 1 for yes and
0 for no or unclear.
2. Equal weighting accounting for unclear
All items were weighted equally but scored 2 for yes, 1 for
unclear and 0 for no.
3. Weighting according to item type
Items which aimed to detect the presence of bias were
scored 3 for yes (items 3, 4, 5, 6, 7, 10, 11, 12), items
which aimed to detect sources of variation between stud-
ies were scored 2 for yes (item 1) and items which were
Table 1: QUADAS and scoring guide for each of the 5 schemes
QUADAS Item Scoring scheme
12345
1 Was the spectrum of patients representative of the patients who will receive the test in practice? 1 2 2 3 10
2 Were selection criteria clearly described? 1 2 1 1 2
3 Is the reference standard likely to correctly classify the target condition? 1 2 3 2 10
4 Is the time period between reference standard and index test short enough to be reasonably sure that the target 
condition did not change between the two tests?
12316
5 Did the whole sample or a random selection of the sample, receive verification using a reference standard of 
diagnosis?
12339
6 Did patients receive the same reference standard regardless of the index test result? 1 2 3 2 7
7 Was the reference standard independent of the index test (i.e. the index test did not form part of the reference 
standard)?
12317
8 Was the execution of the index test described in sufficient detail to permit replication of the test? 1 2 2 1 3
9 Was the execution of the reference standard described in sufficient detail to permit its replication? 1 2 2 1 2
10 Were the index test results interpreted without knowledge of the results of the reference standard? 1 2 3 3 8
11 Were the reference standard results interpreted without knowledge of the results of the index test? 1 2 3 3 6
12 Were the same clinical data available when test results were interpreted as would be available when the test is 
used in practice?
12335
13 Were uninterpretable/ intermediate test results reported? 1 2 1 1 4
14 Were withdrawals from the study explained? 1 2 1 1 3
Total score 14 28 33 26 85
All scoring given above refer to the score which studies that answered "yes" to each question should be given. Studies that answered "no" or 
"unclear" were scored 0 for each scoring system with the exception of system 2 in which studies that scored "unclear" were given 1.BMC Medical Research Methodology 2005, 5:19 http://www.biomedcentral.com/1471-2288/5/19
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related to the quality of reporting were scored 1 for yes
(items 2, 8, 9, 13, 14). All items were scored 0 for no or
unclear.
4. Weighting based on the evidence
The evidence used in the development of QUADAS was
used to determine item weighting[18]. Two systematic
reviews of the diagnostic literature provided an evidence
base for the development of QUADAS. The first was a
review of evidence on factors that can lead to bias or vari-
ation in the results of diagnostic accuracy studies[20]. For
each source of bias or variation, the number of studies
that found that a particular source of bias or variation
impacted on estimates of diagnostic accuracy was summa-
rised. The second review considered all existing quality
assessment tools designed for diagnostic accuracy stud-
ies[17]. The proportion of tools that covered each of a list
of possible items relating to the quality of diagnostic accu-
racy studies was summarised. To estimate quality scores
using this weighting scheme, items for which there was
evidence of bias or variation from at least 5 studies or
which were included in at least 75% of existing quality
assessment tools were scored 3 for yes (items 1, 5, 10, 11,
12); items for which there was evidence of bias from at
least 2 studies and which were included in at least 50% of
existing quality assessment tools were scored 2 points for
yes (items 3, 6). All other items were given 1 point for yes
(items: 4, 7, 8, 9, 13, 14). All items were scored 0 for no or
unclear.
5. Subjective scoring
Each item was scored from 1 – 10 based on one of the
author's subjective opinion of its importance. This
allowed items which the author considered to be of
greater importance to receive a much greater weighting
than items considered less important. For example items
such as inclusion of an appropriate patient spectrum and
the use of an appropriate reference standard were judged
to be much more important than items such as reporting
of selection criteria or details of the reference standard.
This is reflected in the weightings given to these items.
These weighting schemes are summarised in Table 1. Each
different weighting scheme was used to produce an over-
all quality score, giving a total of five different scores for
each study. As the total maximum possible points differed
across the scoring schemes, the scores were expressed as
the percentage of the maximum possible points for each
scoring scheme so that the quality scores could be com-
pared across schemes.
Data set
We selected a data set consisting of 28 studies that looked
at ultrasound for the diagnosis of vesico-ureteral reflux in
children. These came from a systematic review on the
diagnosis and further investigation of urinary tract infec-
tion (UTI) in children under 5[21]. The studies were
selected as they provided a set of studies that were hetero-
geneous in terms of quality and individual study results.
They provide two separate data sets within one larger data
set as they can be split according to the type of ultrasound
used: contrast-enhanced (16 studies) or standard ultra-
sound (12 studies). Although both types of study evalu-
ated ultrasound and so involve similar quality issues,
there were differences in accuracy between the ultrasound
types: contrast-enhanced ultrasound is a much more accu-
rate test for vesico-ureteral reflux in children than
standard-ultrasound.
Thus we were able to investigate whether different quality
scores have the same impact on two separate data sets.
QUADAS was used in this review to assess the quality of
studies. All studies had previously been coded using QUA-
DAS as yes, no or unclear. This coding was carried out by
one reviewer and checked by a second reviewer.
Analysis
Methods for investigating the effects of the quality scores
on test performance We used three different methods to
investigate the effects of quality scores on test perform-
ance. Each method was performed separately for the
standard ultrasound studies and for the contrast-
enhanced ultrasound studies. For each of the steps involv-
ing pooling of studies, standard SROC (summary receiver
operating characteristic) methods were used to pool indi-
vidual study results[22]. The SROC model was estimated
by regressing D (log(DOR), where DOR is the diagnostic
odds ratio) against S (logit (sensitivity) + logit (1-specifi-
city)), weighting according to sample size, for each study.
To account for zero cells in the 2 × 2 tables, 0.5 was added
to every cell for all 2 × 2 tables as recommended by Moses
et al.[22]. All analyses were carried out using STATA ver-
sion 8 (StataCorp, College Station, Texas).
a. Ranking of studies
Studies were ranked according to quality score and we
investigated whether the ranking of each study was differ-
ent according to the method used to weight the quality
scores. This allowed investigation of whether the use of a
summary quality score in a table as an overall indicator of
quality is appropriate.
b. Difference in estimates diagnostic accuracy between high and low 
quality studies
We stratified studies into "high" and "low" quality studies
using the quality score. The median quality score was cal-
culated for each scoring scheme. Studies with scores
higher than the median score were classified as "high"
quality studies, while studies with the median quality
score or lower were classified as "low" quality studies. ABMC Medical Research Methodology 2005, 5:19 http://www.biomedcentral.com/1471-2288/5/19
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relative diagnostic odds ratio (RDOR) was calculated for
each of the different quality scores by dividing the pooled
diagnostic odds ratio (DOR) for the high quality studies
by that for the low quality studies.
c. Quality score as a possible source of heterogeneity
The effects of quality on test performance were investi-
gated using meta-regression analysis. The SROC model
was extended to include "quality score" as a continuous
variable, assuming a linear relationship between quality
score and log DOR. We calculated the RDOR for a 10
point increase in quality by multiplying the coefficient for
the quality score obtained from the regression analysis by
10 and then anti-logging it.
Results
Table 2 summarises the results for the 28 studies included
in this study. It presents the 2 × 2 table results for each
study, the results of the quality assessment, and the sum-
mary quality scores produced using each of the five scor-
ing schemes. Reading table 2 vertically per item allows
readers to make some judgments about which items
might contribute to variations in the scores. Figure 1
shows the results of the studies plotted in receiver operat-
ing characteristic (ROC) space, giving an indication of the
heterogeneity between studies.
a. Ranking of studies
The ranking of the studies using the different quality
scores is summarised in Figure 2. For standard ultrasound,
all scoring schemes ranked the same three studies as being
the best studies, and ranked these in the same order. All
scoring schemes also ranked the same study as being of
the worst quality. For contrast enhanced ultrasound,
scores 1, 2, 3 and 5 ranked the same two studies as being
of the best quality. Score 4 ranked these two studies as
having the second highest quality score. The study ranked
as being the best quality study by score 4 was ranked as
being of intermediate quality by the other scoring
schemes. All scores ranked the same three studies as being
of worst quality, with scores 1, 2, 3 and 4 ranking them in
the same order. For both types of ultrasound the different
scoring schemes ranked the more intermediate quality
studies in different orders.
b. Difference in estimates of diagnostic accuracy between 
high and low quality studies
The RDOR comparing studies classified as "high" to those
classified as "low" quality using each of the five scoring
schemes is shown in Figure 3, separately for standard
ultrasound and contrast enhanced ultrasound. For stand-
ard ultrasound, scores 1,2, and 3 gave RDORs suggesting
that high quality studies produced lower estimates of
diagnostic accuracy than low quality studies. In contrast,
the results from schemes 4 and 5 suggested that there was
no difference in estimates of the DOR between high and
low quality studies. For contrast-enhanced ultrasound,
scores 1, 3, 4 and 5 all classified the same set of studies as
being of high and low quality. The RDORs for these qual-
ity scores suggested that high quality studies produce
higher DORs than low quality studies. In contrast, scheme
2 produced an RDOR suggesting that high quality studies
produce lower estimates of diagnostic accuracy than low
quality studies.
c. Quality score as a possible source of heterogeneity
Figure 4 shows the RDORs for a 10 point increase in qual-
ity score for each of the five different quality scores, sepa-
rately for standard and contrast-enhanced ultrasound. For
standard ultrasound, all scoring schemes suggested that
high quality studies produce lower DORs than low quality
studies. For contrast-enhanced ultrasound, scores 1, 3, 4
and 5 suggested that higher quality studies produce higher
DORs than lower quality studies, while score 2 suggested
that they produced lower estimates. However, the confi-
dence intervals around these estimates were wide and all
included one.
Discussion
This study has shown that using different methods of
weighting individual items from the same quality assess-
ment tool can produce different quality scores. Incorpo-
rating these quality scores into the results of a review can
lead to different conclusions regarding the effect of study
quality on estimates of diagnostic accuracy.
Although the ordering of studies using the different qual-
ity scores were broadly similar, there were some differ-
ences which could lead to different conclusions if they
were used in a systematic review. For example, for the
contrast enhanced ultrasound studies, if quality scoring
scheme 4 or 5 was used then the study by Bergius and col-
leagues[23] would be considered to be one of the best
quality studies. However, if scoring schemes 1, 2, or 3
were used then this study would be considered to be an
average quality study. This suggests that quality scores
should not be used as a summary indicator of quality in
results tables in systematic reviews. Instead either the
results of the whole quality assessment, or key compo-
nents of the quality assessment, should be reported.
Stratifying studies into high and low quality studies
according to quality score also varied according to the
scoring scheme used. Although the confidence intervals
for all comparisons were wide and all but one included
one, the conclusions regarding the association of study
quality and diagnostic accuracy differ according to the
scoring scheme used. It is important to note that in prac-
tice a reviewer would only use one scoring scheme and so
the results from the other scoring schemes would not beB
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Table 2: Individual study results (2 × 2 data), results of the quality assessment, and quality scores using each of the five scoring schemes
Study details 2 × 2 Data QUADAS Results Quality score
TP FP FN TN Spectrum 
composition
Selection 
criteria
Reference 
standard
Disease 
progression
bias
Partial 
verifica-
tion bias
Differential 
verification 
bias
Incorporation 
bias
Test
execution 
details
Reference 
execution 
details
Test 
review 
bias
Diagnostic 
review bias
Clinical 
review 
bias
Uninter-
pretable 
results
With-
drawals
Score 
1
Score 
2
Score 
3
Score 
4
Score 
5
Standard US
Baronciani (1986) [24] 13 4 8 49 + + + ? + + + - - ? ? ? ? ? 43 64 45 46 53
Dura (1997) [25] 3 4 14 27 - + + + + + + + + + + ? + + 86 89 85 77 79
Evans (1999) [26] 2 10 17 84 - + + ? + + + + - ? ? ? + ? 50 68 48 42 49
Foresman (2001) [27] 24 43 25 47 - + + + + + + + - + + ? + + 79 82 79 73 76
Mage (1989) [28] 22 5 19 76 - - + ? + + + + - ? ? ? ? ? 36 57 42 35 42
Mahant (2002) [29] 14 30 21 97 - + + + + + + + - + + ? ? ? 64 75 73 65 68
Morin (1999) [30] 20 41 2 7 - + + + + + + + - ? ? ? ? ? 50 68 55 42 52
Muensterer (2002) [31] 35 76 34 241 - + + + + + + + - ? ? ? ? + 57 71 58 46 55
Oostenbrink (2000) [32] 21 20 16 83 + + + ? - ? + + - + ? ? ? - 43 61 42 42 47
Salih (1994) [33] 26 3 1 12 + - + + + + + - - ? ? ? ? - 43 57 52 46 58
Tan (1988) [34] 3 6 14 32 - - + + + + + + + - - ? ? ? 50 61 58 42 52
Verber (1988) [35] 8 9 20 25 + - + ? - + + + + ? ? ? ? - 43 61 45 38 46
Median Score 50 66 53 44 52
Contrast-enhanced US
Alzen (1994) [36] 20 6 2 73 - - + + + + + - - ? ? ? ? ? 36 54 45 35 46
Bergius (1990) [23] 56 2 14 176 + - + ? + + + + - + + + ? - 64 71 76 81 76
Berrocal (2001) [37] 94 29 10 307 - - + + + + + + - ? ? ? ? ? 43 61 52 38 49
Berrocal Frutos (2000) [38] 63 19 7 204 - + + + + + + + + + + ? + + 86 89 85 77 79
Haberlick (1997) [39] 21 10 9 114 - + + + + + + + - ? ? ? ? ? 50 68 55 42 52
Kessler (1982) [40] 13 0 4 38 - + + ? - + + + - + ? ? ? - 43 57 45 38 44
McEwing (2002) [41] 8 3 8 173 - + + + + + + + - + + ? ? + 71 79 76 69 72
Mentzel (2002) [42] 36 10 4 174 - - + + + + + + + + ? ? + + 71 79 73 62 69
Nakamura (2002) [43] 9 3 2 52 - - + ? + + + + - + + ? ? ? 50 64 61 58 59
Piaggio (2003) [44] 42 35 32 196 - + + ? + + + + + ? ? + ? + 64 79 64 58 56
Radmayr (2002) [44] 71 5 3 129 - - + + + + + + + + + ? + + 79 82 82 73 76
Schneider (1984) [45] 46 15 17 141 - + + + + + + + + + + ? ? ? 71 82 79 69 71
Siamplis (1996) [46] 15 4 3 154 - + + + + + + + - ? ? ? + ? 57 71 58 46 56
Valentini (2001) [47] 34 4 8 72 - - + + + + + + + - - ? ? ? 50 61 58 42 52
Uhl (2003) [48] 16 0 3 28 + + + + + + + - - + ? ? + ? 64 75 67 65 74
Von Rohden (1995) [49] 6 0 1 19 - + + + + + + + + + + ? + + 86 89 85 77 79
Median score 64 73 65 60 64
TP = true positives; FP = false positives; FN = false negatives; TN = true negatives + = yes; - = no; ? = unclearBMC Medical Research Methodology 2005, 5:19 http://www.biomedcentral.com/1471-2288/5/19
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available to them: they would have to draw conclusions
from the results for the single scoring scheme that they
selected. For standard ultrasound, two of the schemes
assessed produced an overall quality score that suggested
no association between study quality and the diagnostic
odds ratio. However, if the other three schemes were used
then the conclusion would have been that high quality
studies tend to produce lower estimates of diagnostic
accuracy than low quality studies. Similarly for contrast-
enhanced ultrasound, the conclusion for four of the scor-
ing schemes was that high quality studies tend to produce
higher estimates of diagnostic accuracy than low quality
studies. In contrast, if the other scoring scheme had been
used the conclusions would have been reversed. These
results suggest that the use of quality scores to stratify
studies into high and low quality studies should be
avoided.
The inclusion of quality score as a continuous variable in
the meta-regression showed fewer differences between
scoring schemes. There were larger associations between
quality score and the DOR for standard ultrasound than
for contrast enhanced ultrasound. This would be expected
as there was more heterogeneity between studies of stand-
ard ultrasound and so there was more variation that could
have been explained by differences in quality. For stand-
ard ultrasound the direction of the association between
study quality and test performance was the same for all
scoring schemes. For contrast enhanced ultrasound the
associations reported for quality scores were close to one
with wide confidence intervals. This suggests very little
association between quality score and diagnostic
accuracy, although scoring scheme 2 again produced an
association in the opposite direction to the other scoring
schemes. The investigation of the association of an overall
quality score with a summary effect estimate can be com-
plicated. If no association is found between the two, this
does not mean that quality does not affect the summary
estimate. It may be that there is no association with any of
the components of quality incorporated into the score;
there may be associations with one or more components
but that these have very little weight and are lost in the
overall quality score; or it may be that there are associa-
tion with two or more components but that these act in
opposite directions cancelling each other out[7].
It is interesting to note that for the contrast enhanced
ultrasound studies that it was generally scoring scheme 2
that produced different results to the other scoring
schemes. All other scoring schemes scored studies that
answered "unclear" to an item in the same way as studies
that answered "no". Scoring scheme 2 scored these studies
higher than those that answered "no". The difference
between scoring scheme 2 and the other scoring schemes
may therefore be related to the quality of reporting of
studies: studies that were poorly reported and answered
"unclear" to many of the QUADAS items would be rated
higher using this scoring scheme than the other schemes.
The results of this study support the finding of Juni and
colleagues that using summary scores to identify high
quality studies is problematic[9]. We did not find such
large differences between the different scoring schemes
included in this study as Juni et al. This would be expected
as we were using different methods of weighting the same
quality assessment tool whereas they used different qual-
ity assessment tools, each of which not only weighted
items differently but also included different items. In
addition, we used only five different scoring schemes
whereas Juni et al. used 25 different quality scales.
Our study was limited by the relatively few primary stud-
ies included: for standard ultrasound we included 12
studies, and for contrast-enhanced ultrasound we
included 16 studies. The greater the number of studies
included in a meta-analysis, the greater the power for
detecting associations between study quality and esti-
mates of diagnostic accuracy. If additional primary studies
had been available, more precise estimates of the
association between quality score and diagnostic accuracy
would have been produced and the differences between
these associations for the different scoring schemes could
have been assessed in more detail. An additional
Estimates of sensitivity and 1-specificity plotted in ROC  space for standard and contrast enhanced ultrasound Figure 1
Estimates of sensitivity and 1-specificity plotted in ROC 
space for standard and contrast enhanced ultrasoundBMC Medical Research Methodology 2005, 5:19 http://www.biomedcentral.com/1471-2288/5/19
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limitation was the poor quality of the reporting of the
studies. This resulted in a large proportion of "unclear"
responses to the quality assessment.
A further limitation of this study was the lack of a gold
standard against which to compare the quality scoring
schemes. Lack of agreement between different scoring sys-
tems could be expected and does not necessarily invali-
date all the scoring systems. The problem in this situation
is determining which quality scoring scheme is the most
valid. This is an inherent problem with using a quality
score, and there is no reliable way of doing this.
Conclusion
This study, in the area of diagnostic systematic reviews,
supports the evidence from previous work in the area of
therapeutics suggesting that quality scores should not be
incorporated into systematic reviews. Incorporation of the
results of the quality assessment into the systematic
review should involve a component approach, where the
ranking of studies according to each different quality score Figure 2
ranking of studies according to each different quality scoreBMC Medical Research Methodology 2005, 5:19 http://www.biomedcentral.com/1471-2288/5/19
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association of individual quality items with test accuracy
are investigated individually, rather than using a com-
bined quality score.
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